DoD Autism Clinical Translational Research Award

archived

The ARP Clinical Translational Research Award is intended to support early-phase, proof-of-principle translational studies that will examine hypothesis-based, innovative interventions that have the potential to address current clinical deficits for ASD. Applications are strongly encouraged to address one of the ARP Clinical Translational Research Award Areas of Interest. If the proposed project does not address any of the FY18 ARP Clinical Translational Research Award Areas of Interest, the application should describe how the project will nevertheless address a critical need of the ASD community. Outcomes from studies funded by this award are anticipated to provide scientific rationale for subsequent development of larger, efficacy-based clinical trials of interventions that will transform ASD clinical care. The FY18 ARP Clinical Translational Research Award seeks applications for early-phase clinical research, and strongly encourages applications that address the critical needs of the ASD community in one or more of the following areas of interest: • Behavioral, cognitive, and other non-pharmacological therapies • Environmental risk factors • Pharmacological, genetic, and other biological treatments in ASD • Dissemination and/or implementation of clinically validated interventions • Therapies to alleviate conditions co-occurring with ASD (e.g., including, but not limited to, sleep disturbances, gastrointestinal issues, inflammation, aggression, depression, anxiety, attention deficit, seizures) • Interventions promoting success in key transitions to adulthood for individuals living with ASD • Healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD across the lifespan and the continuum of care (i.e., primary care, urgent/emergent care, and disaster relief) • Improve diagnosis across the lifespan • Cultural and socioeconomic factors in treatment efficacy, delivery, and access to services

High